Hangover, Congeners, Sleep and Occupational Performance
NCT ID: NCT00247585
Last Updated: 2006-12-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
140 participants
INTERVENTIONAL
2003-09-30
2006-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. relative to placebo, heavy drinking will degrade next-day performance, and this relationship will be mediated in full or in part by quality of sleep;
2. a high congener alcoholic beverage will affect performance to a greater degree than a low congener beverage and this relationship will be mediated by severity of hangover symptoms.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. relative to placebo, heavy drinking will degrade next-day cognitive performance, and this relationship will be mediated in full or in part by quality of sleep; and
2. a high congener alcoholic beverage will affect performance to a greater degree than a low congener beverage and this relationship will be mediated by severity of hangover symptoms.
We will explore whether the residual effects of heavy drinking on next-day cognitive performance are attenuated among participants positive for a family history of alcohol problems, relative to family-history-negative participants.
A secondary aim is to test the effectiveness of the Psychomotor Vigilance Test (PVT), a validated measure of fatigue, as a fitness-for-duty test. We will test whether the PVT can distinguish dosing status (alcohol or placebo) of participants at the time performance is measured the next day and the extent to which PVT measures correlate with performance scores.
Participants will be young adults ages 21-30 who are currently enrolled in an undergraduate college or university or have graduated from a college or university. Alcoholic beverages will be bourbon (high-congener) in soda or vodka (low-congener) in soda. Placebo will be tonic alone. We will use a mixed within- and between-subjects design, balancing the order of placebo and alcohol administration. Performance will be measured using a computer-based neurobehavioral evaluation system.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ethanol (Bourbon or Vodka)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently enrolled or have completed college/university
* Have had 5 or more drinks (4 if female) in the last 30 days
* Score less than a 5 on the Short Michigan Alcohol Screening Test (SMAST)
* No self-reported history of counseling or treatment for substance abuse
* Not taking any medication contraindicated for alcohol use or that disrupts sleep
* Doesn't have a health condition contraindicated for alcohol use
* Has not been diagnosed with a primary sleep disorder
* Has not been diagnosed with a mental health disorder
* Not currently working night shifts at a job
* Not routinely taking medications that affect sleep
* No evidence of extreme morningness or eveningness as assessed by questionnaire
* Not a regular smoker
Exclusion Criteria
* Not currently enrolled or has not completed college/university
* Hasn't had 5 or more drinks (4 if female) in the last 30 days (not a regular drinker)
* Score greater than or equal to 5 on the Short Michigan Alcohol Screening Test (SMAST)
* Self-reported history of counseling or treatment for substance abuse
* Taking any medication contraindicated for alcohol use or that disrupts sleep
* Has a health condition contraindicated for alcohol use
* Has been diagnosed with a primary sleep disorder
* Has been diagnosed with a mental health disorder
* Currently working night shifts at a job
* Routinely taking medications that affect sleep
* Evidence of extreme morningness or eveningness as assessed by questionnaire
* Is a regular smoker
* Not a regular drinker
* Is pregnant or nursing
21 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan Howland, PhD, MPH, MPA
Role: PRINCIPAL_INVESTIGATOR
Boston University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Clinical Research Center, Boston University School of Public Health/Boston Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH Grant R01 AA12087-04A1
Identifier Type: -
Identifier Source: secondary_id
NIAAAHOW12087
Identifier Type: -
Identifier Source: org_study_id